Ann: Presentation slides - J.P. Morgan Healthcare Conference, page-104

I was about to post this but you’ve beaten me to it. Quite normal for high growth companies pitching to investors to use these words. Investor pitching 101, and I’m more than happy for management to be using this rhetoric as they can back it up with last few quarters results.

I can’t find who critiqued the price comments on the product features slide my only comment is that agree it’s not a product feature but absolutely would be a lead call out pitching at a conference like this. It’s semantics; they’re not talking to surgeons here; it’s a simple pitch to investors. Don’t get lost or read into it to much - you’re missing the point here